Kayıkçıoglu, Erkan, and Eda Findos. “The Prognostic Immune Nutritional Index Is a Predictive Biomarker in Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone or Enzalutamide: Prognostic Immune Nutritional Index and Prostate Adenocancer”. The Injector 1, no. 3 (November 17, 2022): 106–114. Accessed July 17, 2024. https://injectormedicaljournal.com/index.php/theinjector/article/view/56.